Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001839882-25-011949
Filing Date
2025-02-27
Accepted
2025-02-27 18:44:51
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 - MORRIS morris_form4-022725.html 4  
1 FORM 4 - MORRIS morris_form4-022725.xml 4 8093
  Complete submission text file 0001839882-25-011949.txt   9679
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
MORRIS JESSICA EDGAR (Reporting) CIK: 0001656531 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 25681645